Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in <i>Mycobacterium tuberculosis</i>
New drugs with new mechanisms of action are urgently required to tackle the global tuberculosis epidemic. Following the FDA-approval of the ATP synthase inhibitor bedaquiline (Sirturo<sup>®</sup>), energy metabolism has become the subject of intense focus as a novel pathway to exploit fo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-03-01
|
| Series: | Applied Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3417/10/7/2339 |